Curaleaf Teams Up With Southern Glazer's Alcohol Beverage To Distribute Hemp & Select CBD Lines

Curaleaf Holdings, Inc. CURA CURLF announced Tuesday that it has inked a national distribution agreement with Southern Glazer's Wine & Spirits, a distributor of beverage alcohol.

What Happened?

The deal brings Curaleaf's lineup of products from their hemp and Select CBD lines into Southern Glazer's distribution network.

The new partnership combines Curaleaf's expertise in creating high-quality non-psychoactive hemp products with Southern Glazer's national scale, unmatched route-to-market capabilities, state-of-the-market sales team and its industry-leading Proof e-commerce platform bringing operating efficiencies that will drive growth within Curaleaf's family of CBD products said the Wakefield, Massachusetts company.

"We are delighted to be joining forces with a world-leading beverage distributor that shares our values around responsible distribution and pioneering a well-regulated industry," said Joseph Gennaro, VP of CBD, health and wellness at Curaleaf.

What's Next?

Both Curaleaf and Glazer's Wine & Spirits look forward to introducing new innovations to both ancillary lines with confections and beverages that feature minor cannabinoids like CBN and CBG, allowing consumers to personalize their CBD experiences as they continue to learn which products will work best for their unique needs.

"We are excited to add Curaleaf to our distribution network, as we are aligned on the future growth potential of CBD in the U.S. and, as such, are both investing significantly in the category," David Chaplin, chief growth officer at Southern Glazer's said.

Southern Glazer's is "uniquely positioned to deliver the most effective route-to-market for Curaleaf," Chaplin added.

Kariff Rhooms, VP at SG Ventures and head of Southern Glazer's CBD sales division, said the beverage distributor's team has "the expertise and experience to engage more consumers through our network of retail customers as we work with Curaleaf to continue to grow the CBD category."

More recent news from Curaleaf:

Why Curaleaf Should Be A Core Holding In Any US MSO Portfolio: Analyst's Take On Q3 Earnings

Curaleaf' On Track To Achieve $1.2 To $1.3B Annual Revenue Guidance,' Q3 Revenue Grows 74% YoY

Will $286M Tryke Deal Improve Curaleaf's Operating Margin? Analyst's Thoughts Ahead Earnings

Curaleaf Bolsters Presence In Three Key Growth Markets Via $286M Acquisition Of Tryke Companies